Recent developments on 3-hydroxy-4-pyridinones with respect to their clinical applications

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1

Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139 · see citing works

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00423-1 · Cited by 11,484 · see citing works

Role of angiogenesis in tumor growth and metastasis

Folkman, J. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70065-1 · Cited by 2,862 · see citing works

Role of angiogenesis in tumor growth and metastasis

Folkman, J. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.37263 · Cited by 2,424 · see citing works

Designed Multiple Ligands. An Emerging Drug Discovery Paradigm

Morphy, R., & Ranković, Z. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm058225d · Cited by 1,237 · see citing works

Blood–brain barrier delivery

Pardridge, W. M. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.10.013 · Cited by 1,191 · see citing works

Multi-target therapeutics: when the whole is greater than the sum of the parts

Zimmermann, G. R., Lehár, J., & Keith, C. T. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2006.11.008 · Cited by 1,105 · see citing works

Hereditary Hemochromatosis — A New Look at an Old Disease

Pietrangelo, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra031573 · Cited by 992 · see citing works

Vanadium Compounds as Insulin Mimics

Thompson, K. H., McNeill, J. H., & Orvig, C. (1999) · Chemical Reviews · doi:10.1021/cr980427c · Cited by 692 · see citing works

IMPACT OF SEXUAL AND PHYSICAL ABUSE ON WOMEN'S MENTAL HEALTH

Mullen, P., Walton, V. A., Romans, S. E., & Herbison, P. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91600-5 · Cited by 592 · see citing works

Tumor scanning with 67Ga citrate.

Edwards, C. L., & Hayes, R. L. (1969) · PubMed · Cited by 468 · see citing works

The toxicology of aluminum in the brain: a review.

Yokel, R. A. (2000) · PubMed · Cited by 461 · see citing works

Radiometal-Labeled Agents (Non-Technetium) for Diagnostic Imaging

Anderson, C. J., & Welch, M. J. (1999) · Chemical Reviews · doi:10.1021/cr980451q · Cited by 455 · see citing works

OSTEOMALACIC DIALYSIS OSTEODYSTROPHY: EVIDENCE FOR A WATER-BORNE ÆTIOLOGICAL AGENT, PROBABLY ALUMINIUM

Ward, M. K., Ellis, H. A., Feest, T., Parkinson, I. S., Kerr, D. N. S., Herrington, J., & Goode, G. L. (1978) · The Lancet · doi:10.1016/s0140-6736(78)90191-5 · Cited by 433 · see citing works

Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia

Anderson, L. J., Wonke, B., Prescott, E., Holden, S., Walker, J. M., & Pennell, D. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09740-4 · Cited by 431 · see citing works

Long-Term Safety and Effectiveness of Iron-Chelation Therapy with Deferiprone for Thalassemia Major

Olivieri, N. F., Brittenham, G. M., McLaren, C. E., Templeton, D. M., Cameron, R., MCCLELLAND, R. A., Burt, A. D., & Fleming, K. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808133390701 · Cited by 418 · see citing works

The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy

Gaeta, A., & Hider, R. C. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706416 · Cited by 411 · see citing works

Aluminium speciation in relation to aluminium bioavailability, metabolism and toxicity

Berthon, G. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00021-8 · Cited by 366 · see citing works

Next Generation, High Relaxivity Gadolinium MRI Agents

Raymond, K. N., & Pierre, V. C. (2004) · Bioconjugate Chemistry · doi:10.1021/bc049817y · Cited by 328 · see citing works

Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions

Neufeld, E. J. (2006) · Blood · doi:10.1182/blood-2006-02-002394 · Cited by 317 · see citing works

Metal complexes in medicinal chemistry: new vistas and challenges in drug design

Thompson, K. H., & Orvig, C. (2005) · Dalton Transactions · doi:10.1039/b513476e · Cited by 299 · see citing works

Design of clinically useful iron(III)‐selective chelators

Liu, Z. D., & Hider, R. C. (2002) · Medicinal Research Reviews · doi:10.1002/med.1027 · Cited by 266 · see citing works

Absence of aluminium in neuritic plaque cores in Alzheimer's disease

Landsberg, J., Mcdonald, B., & Watt, F. (1992) · Nature · doi:10.1038/360065a0 · Cited by 254 · see citing works

Inorganic Biochemistry of Iron Metabolism: From Molecular Mechanisms to Clinical Consequences

Crichton, R. R. (2001) · Cited by 244 · see citing works

Risk for neuropathologically confirmed Alzheimer's disease and residual aluminum in municipal drinking water employing weighted residential histories

McLachlan, D. R. C., Bergeron, C., Smith, J. E., Boomer, D., & Rifat, S. L. (1996) · Neurology · doi:10.1212/wnl.46.2.401 · Cited by 233 · see citing works

Combined therapy with deferiprone and desferrioxamine

Wonke, Wright, & Hoffbrand, V. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.01002.x · Cited by 217 · see citing works

A biogeochemical cycle for aluminium?

Exley, C. (2003) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(03)00274-5 · Cited by 180 · see citing works

Aluminum chelation principles and recent advances

Yokel, R. A. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00078-4 · Cited by 175 · see citing works

Stability constants for complexes of the siderophore desferrioxamine B with selected heavy metal cations

Hernlem, B. J., Vane, L. M., & Sayles, G. D. (1996) · Inorganica Chimica Acta · doi:10.1016/0020-1693(95)04780-8 · Cited by 160 · see citing works

Metal complexes of maltol and close analogues in medicinal inorganic chemistry

Thompson, K. H., Barta, C. A., & Orvig, C. (2006) · Chemical Society Reviews · doi:10.1039/b416256k · Cited by 149 · see citing works

Arylpiperazine Derivatives Acting at 5-HT1A Receptors

López-Rodríguez, M. L., Ayala, D., Benhamú, B., Morcillo, M., & Viso, A. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867023371030 · Cited by 144 · see citing works

Stoffwechselprodukte von Actinomyceten. 27. Mitteilung. Über die Konstitution von Ferrioxamin B

Bickel, H., Hall, G. E., KELLER‐SCHIERLEIN, W., Prelog, V., Vischer, E., & Wettstein, A. (1960) · Helvetica Chimica Acta · doi:10.1002/hlca.19600430732 · Cited by 143 · see citing works

Stabilities of the iron(III) chelates of 1,2-dimethyl-3-hydroxy-4-pyridinone and related ligands

Motekaitis, R. J., & Martell, A. E. (1991) · Inorganica Chimica Acta · doi:10.1016/s0020-1693(00)82997-7 · Cited by 136 · see citing works

Advances in Iron Overload Therapies. Prospects for Effective Use of Deferiprone (L1), Deferoxamine, the New Experimental Chelators ICL670, GT56-252, L1NAll and their Combinations

Kontoghiorghes, G. J., Eracleous, E., Economides, C. P., & Kolnagou, A. (2005) · Current Medicinal Chemistry · doi:10.2174/092986705774463003 · Cited by 125 · see citing works

Molecular Mechanisms of Iron Uptake by Cells and the Use of Iron Chelators for the Treatment of Cancer

Richardson, D. R. (2005) · Current Medicinal Chemistry · doi:10.2174/092986705774462996 · Cited by 123 · see citing works

Iron Chelator Research: Past, Present, and Future

Tam, T. F., Leung-Toung, R., Li, W., Wang, Y., Karimian, K., & Spino, M. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457593 · Cited by 117 · see citing works

Novel 3-hydroxy-2(1H)-pyridinones. Synthesis, iron(III)-chelating properties and biological activity

Streater, M., Taylor, P. D., Hider, R. C., & Porter, J. B. (1990) · Journal of Medicinal Chemistry · doi:10.1021/jm00168a033 · Cited by 115 · see citing works

Iron chelating agents in clinical practice

Faa, G., & Crisponi, G. (1999) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(99)00056-9 · Cited by 109 · see citing works

Equilibrium constants for the binding of aluminum to human serum transferrin

Harris, W. R., & Sheldon, J. (1990) · Inorganic Chemistry · doi:10.1021/ic00326a024 · Cited by 101 · see citing works

Speciation and structural aspects of interactions of Al(III) with small biomolecules

Rubini, P., Lakatos, A., Champmartin, D., & Kiss, T. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(01)00467-2 · Cited by 94 · see citing works

Iron-chelating therapy with the new oral agent ICL670 (Exjade®)

Cappellini, M. D. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.09.002 · Cited by 91 · see citing works

Redox cycling of iron by Aβ42

Khan, A., Dobson, J., & Exley, C. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.09.013 · Cited by 90 · see citing works

Synthesis, Physicochemical Characterization, and Biological Evaluation of 2-(1‘-Hydroxyalkyl)-3-hydroxypyridin-4-ones: Novel Iron Chelators with Enhanced pFe3+ Values

Liu, Z. D., Khodr, H., Liu, D. Y., Lu, S. L., & Hider, R. C. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm991080o · Cited by 89 · see citing works

Multifunctional drugs with different CNS targets for neuropsychiatric disorders

der Schyf, C. J. V., Geldenhuys, W. J., & Youdim, M. B. H. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04141.x · Cited by 88 · see citing works

A novel trivalent cation chelator Feralex dissociates binding of aluminum and iron associated with hyperphosphorylated τ of Alzheimer’s disease

Shin, R., Kruck, T. P. A., Murayama, H., & Kitamoto, T. (2003) · Brain Research · doi:10.1016/s0006-8993(02)03893-3 · Cited by 88 · see citing works

Insulinomimetic bis(maltolato)zinc(II) Complex: Blood Glucose Normalizing Effect in KK-Ay Mice with Type 2 Diabetes Mellitus

Yoshikawa, Y., Ueda, E., Miyake, H., Sakurai, H., & Kojima, Y. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4456 · Cited by 76 · see citing works

Emerging Understanding of the Advantage of Small Molecules such as Hydroxypyridinones in the Treatment of Iron Overload

Hider, R. C., & Zu, L. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457629 · Cited by 75 · see citing works

Acute aluminum encephalopathy in a dialysis center caused by a cement mortar water distribution pipe

Berend, K., van der Voet, G., & Boer, W. H. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.059002746.x · Cited by 74 · see citing works

Metal‐based Neurodegeneration

Crichton, R. R., & Ward, R. J. (2005) · Wiley eBooks · doi:10.1002/0470022574 · Cited by 73 · see citing works

Hydroxypyridinone complexes with aluminium. In vitro/vivo studies and perspectives

Santos, M. A. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00035-8 · Cited by 73 · see citing works

Iron chelation using subcutaneous infusions of diethylene triamine penta‐acetic acid (DTPA)

Pippard, M. J., Jackson, M. J., Hoffman, K., Petrou, M., & Modell, C. B. (1986) · Scandinavian Journal of Haematology · doi:10.1111/j.1600-0609.1986.tb02282.x · Cited by 73 · see citing works

5HT Antagonists Attenuate MK801-Impaired Radial Arm Maze Performance in Rats

Boast, C. A., Bartolomeo, A. C., Morris, H., & Moyer, J. A. (1999) · Neurobiology of Learning and Memory · doi:10.1006/nlme.1998.3886 · Cited by 72 · see citing works

Chelating Agents Used for Plutonium and Uranium Removal in Radiation Emergency Medicine

Fukuda, S. (2005) · Current Medicinal Chemistry · doi:10.2174/092986705774463012 · Cited by 65 · see citing works

Superoxide and Nitric Oxide in Pathological Conditions Associated with Iron Overload. The Effects of Antioxidants and Chelators

Afanasʹev, I. B. (2005) · Current Medicinal Chemistry · doi:10.2174/092986705774462941 · Cited by 62 · see citing works

Molecular Shuttle Chelation: The Use of Ascorbate, Desferrioxamine and Feralex-G in Combination to Remove Nuclear Bound Aluminum

Kruck, T. P. A., Cui, J.-G., Percy, M. E., & Lukiw, W. J. (2004) · Cellular and Molecular Neurobiology · doi:10.1023/b:cemn.0000022773.70722.b2 · Cited by 59 · see citing works

Evaluation of new iron chelators and their therapeutic potential

Aouad, F., Florence, A., Zhang, Y., Collins, F., Henry, C., Ward, R. J., & Crichton, R. R. (2002) · Inorganica Chimica Acta · doi:10.1016/s0020-1693(02)01040-x · Cited by 58 · see citing works

Spontaneous Resolution: From Three-Dimensional Crystals to Two-Dimensional Magic Nanoclusters

Lahav, M., & Leiserowitz, L. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990903)38:17 · Cited by 58 · see citing works

N-Carboxyalkyl derivatives of 3-hydroxy-4-pyridinones: synthesis, complexation with Fe(III), Al(III) and Ga(III) and in vivo evaluation

Santos, M. A., Gil, M., Marques, S. M., Gano, L., Cantinho, G., & Chaves, S. (2002) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(02)00483-x · Cited by 56 · see citing works

Carbohydrate-Appended 3-Hydroxy-4-pyridinone Complexes of the [M(CO)3]+ Core (M = Re, 99mTc, 186Re)

Ferreira, C. L., Bayly, S. R., Green, D. E., Storr, T., Barta, C. A., Steele, J., Adam, M. J., & Orvig, C. (2006) · Bioconjugate Chemistry · doi:10.1021/bc060085e · Cited by 55 · see citing works

Synthesis, characterization, and biological relevance of hydroxypyrone and hydroxypyridinone complexes of molybdenum

Lord, S. J., Epstein, N. A., Paddock, R. L., Vogels, C. M., Hennigar, T. L., Zaworotko, M. J., Taylor, N. J., Driedzic, W. R., Broderick, T. L., & Westcott, S. A. (1999) · Canadian Journal of Chemistry · doi:10.1139/v99-111 · Cited by 53 · see citing works

Evaluation of potential aluminum chelators in vitro by aluminum solubilization ability, aluminum mobilization from transferrin and the octanol/aqueous distribution of the chelators and their complexes with aluminum.

Yokel, R. A., Datta, A. K., & Jackson, E. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24763-2 · Cited by 53 · see citing works

Molecular Factors and Mechanisms Affecting Iron and Other Metal Excretion or Absorption in Health and Disease. The Role of Natural and Synthetic Chelators

Kontoghiorghes, G. J., & Kolnagou, A. (2005) · Current Medicinal Chemistry · doi:10.2174/092986705774463030 · Cited by 50 · see citing works

Bifunctional 3-hydroxy-4-pyridinone derivatives as potential pharmaceuticals: synthesis, complexation with Fe(III), Al(III) and Ga(III) and in vivo evaluation with 67Ga

Santos, M. A., Gil, M., Gano, L., & Chaves, S. (2005) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-005-0003-7 · Cited by 49 · see citing works

Synthesis of a Ligand Based upon a New Entry into the 3-Hydroxy-N-alkyl-2(1H)-pyridinone Ring System and Thermodynamic Evaluation of Its Gadolinium Complex

Johnson, A. R., O'Sulliva, B., & Raymond, K. N. (2000) · Inorganic Chemistry · doi:10.1021/ic991471t · Cited by 48 · see citing works

A new bis(3-hydroxy-4-pyridinone)-IDA derivative as a potential therapeutic chelating agent. Synthesis, metal-complexation and biological assays

Santos, M. A., Gama, S., Gano, L., Cantinho, G., & Farkas, E. (2004) · Dalton Transactions · doi:10.1039/b409357g · Cited by 48 · see citing works

Carbohydrate-Bearing 3-Hydroxy-4-pyridinonato Complexes of Gallium(III) and Indium(III)

Green, D. E., Ferreira, C. L., Stick, R. V., Patrick, B. O., Adam, M. J., & Orvig, C. (2005) · Bioconjugate Chemistry · doi:10.1021/bc0501808 · Cited by 40 · see citing works

Tris(pyrone) Chelates of Gd(III) as High Solubility MRI-CA

Puerta, D. T., Botta, M., Jocher, C. J., Werner, E. J., Avedano, S., Raymond, K. N., & Cohen, S. M. (2006) · Journal of the American Chemical Society · doi:10.1021/ja057954f · Cited by 39 · see citing works

Design and characterisation of novel hexadentate 3-hydroxypyridin-4-one ligands

Piyamongkol, S., Zhou, T., Liu, Z. D., Khodr, H., & Hider, R. C. (2005) · Tetrahedron Letters · doi:10.1016/j.tetlet.2004.12.115 · Cited by 38 · see citing works

Advances in oral iron chelation in man.

Kontoghiorghes, G. J. (1992) · PubMed · Cited by 36 · see citing works

Influence of Hydroxypyridones and Desferrioxamine on the Mobilization of Aluminium from Tissues of Aluminium-loaded Rats

Florence, A., Gauthier, A., Ward, R. J., & Crichton, R. R. (1995) · Neurodegeneration · doi:10.1006/neur.1995.0054 · Cited by 34 · see citing works

Combined Therapy with Deferoxamine and Deferiprone

Kattamis, A. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.020 · Cited by 33 · see citing works

Future Chelation Monotherapy and Combination Therapy Strategies in Thalassemia and Other Conditions. Comparison of Deferiprone, Deferoxamine, ICL670, GT56-252, L1NAll and Starch Deferoxamine Polymers

Kontoghiorghes, G. J. (2006) · Hemoglobin · doi:10.1080/03630260600642674 · Cited by 33 · see citing works

Synthesis of feralex a novel aluminum/iron chelating compound

Kruck, T. P. A., & Burrow, T. E. (2002) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(01)00372-5 · Cited by 32 · see citing works

Therapeutic potential of iron chelators in diseases associated with iron mismanagement

Weinberg, E. D. (2006) · The Journal of pharmacy and pharmacology · doi:10.1211/jpp.58.5.0001 · Cited by 29 · see citing works

Alkylaryl-amino derivatives of 3-hydroxy-4-pyridinones as aluminium chelating agents with potential clinical application

Chaves, S., Gil, M., Marques, S. M., Gano, L., & Santos, M. A. (2003) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(03)00238-1 · Cited by 25 · see citing works

Synthesis and Antiviral Evaluation of Cyclic and Acyclic 2-Methyl-3-hydroxy-4-pyridinone Nucleoside Derivatives

Barral, K., Balzarini, J. M., Neyts, J. H., Clercq, E. D., Hider, R. C., & Camplo, M. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0504306 · Cited by 24 · see citing works

Complexation of Molybdenum(VI) with Bis(3‐hydroxy‐4‐pyridinone)amino Acid Derivatives

Santos, M. A., Gama, S., Pessoa, J. C., Oliveira, M. C., Tóth, I., & Farkas, E. (2007) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.200601088 · Cited by 22 · see citing works

Crystal Structure and Conformational Studies of the Ferric Hexadentate N,N,N-Tris[2-(3-hydroxy-2-oxo-1,2-dihydropyridin-1-yl)acetamido]ethylamine Complex (FeCP130) as a Specific Iron(III) Chelator

Xiao, G., der Helm, D. V., Hider, R. C., & Dobbin, P. S. (1995) · Inorganic Chemistry · doi:10.1021/ic00109a038 · Cited by 22 · see citing works

Chelation of aluminium by combining DFO and L1 in rats

Blanuša, M., Prester, L., Varnai, V. M., Pavlović, D., Kostial, K., Jones, M. M., & Singh, P. K. (2000) · Toxicology · doi:10.1016/s0300-483x(00)00214-6 · Cited by 22 · see citing works

Bis(3-hydroxy-4-pyridinone)-EDTA derivative as a potential therapeutic Al-chelating agent. Synthesis, solution studies and biological assays

Santos, M. A., Gama, S., Gano, L., & Farkas, E. (2005) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2005.06.022 · Cited by 22 · see citing works

Aluminum and Alzheimer's disease: A Vexata Questio between uncertain data and a lot of imagination

Zatta, P. F. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-10106 · Cited by 17 · see citing works

Age‐Related Differences on Aluminium Mobilization by Chelating Agents in Aluminium‐Loaded Uraemic Rats

Esparza, J. L., Gómez, M., Domingo, J. L., Castillo, D. D., & Hernández, M. (2000) · Pharmacology & Toxicology · doi:10.1111/j.0901-9928.2000.870106.x · Cited by 14 · see citing works

The Role of Aluminum in Neurotoxic and Neurodegenerative Processes

Kiss, T., Gajda‐Schrantz, K., & Zatta, P. F. (2006) · doi:10.1002/0470028114.ch13 · Cited by 7 · see citing works

6-Alkoxymethyl-3-hydroxy-4H-pyranones: potential ligands for cell-labelling with indium

Ellis, B. L., Sampson, C. B., Abeysinghe, R. D., Porter, J. B., & Hider, R. C. (1999) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050471 · Cited by 7 · see citing works

A New Approach for Potential Combined Chelation Therapy Using Mono- and Bis-Hydroxypyridinones

Santos, M. A., Gama, S., Gil, M., & Gano, L. (2008) · Hemoglobin · doi:10.1080/03630260701726939 · Cited by 7 · see citing works

Iron(iii) selective molecular and supramolecular fluorescent probes

Sahoo, S. K., Sharma, D., Bera, R. K., Crisponi, G., & Callan, J. F. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35152h · Cited by 774 · see citing works

Speciation Studies of Bifunctional 3-Hydroxy-4-Pyridinone Ligands in the Presence of Zn2+ at Different Ionic Strengths and Temperatures

Irto, A., Cardiano, P., Cataldo, S., Chand, K., Cigala, R. M., Crea, F., Stefano, C. D., Gattuso, G., Muratore, N., Pettignano, A., et al. (2019) · Molecules · doi:10.3390/molecules24224084 · Cited by 239 · see citing works

The Renaissance of the 68Ge/68Ga Radionuclide Generator Initiates New Developments in 68Ga Radiopharmaceutical Chemistry

Roesch, F., & Riss, P. J. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610793176738 · Cited by 186 · see citing works

Hydroxypyridinones as “privileged” chelating structures for the design of medicinal drugs

Santos, M. A., Marques, S. M., & Chaves, S. (2011) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2011.08.008 · Cited by 130 · see citing works

An update on the novel and approved drugs for Alzheimer disease

Alhazmi, H. A., & Albratty, M. (2022) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2022.10.004 · Cited by 122 · see citing works

The binding, transport and fate of aluminium in biological cells

Exley, C., & Mold, M. J. (2014) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2014.11.002 · Cited by 116 · see citing works

Is the Reactivity of M(II)−Arene Complexes of 3-Hydroxy-2(1 H )-pyridones to Biomolecules the Anticancer Activity Determining Parameter?

Hanif, M., Henke, H., Meier, S. M., Martić, S., Labib, M., Kandioller, W., Jakupec, M. A., Arion, V. B., Kraatz, H., Keppler, B. K., et al. (2010) · Inorganic Chemistry · doi:10.1021/ic1009785 · Cited by 104 · see citing works

Chelating agents for human diseases related to aluminium overload

Crisponi, G., Nurchi, V. M., Bertolasi, V., Remelli, M., & Faa, G. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2011.06.013 · Cited by 103 · see citing works

Pyrone derivatives and metals: From natural products to metal-based drugs

Kandioller, W., Kurzwernhart, A., Hanif, M., Meier, S. M., Henke, H., Keppler, B. K., & Hartinger, C. G. (2010) · Journal of Organometallic Chemistry · doi:10.1016/j.jorganchem.2010.11.010 · Cited by 96 · see citing works

Design concepts of half-sandwich organoruthenium anticancer agents based on bidentate bioactive ligands

Tremlett, W. D. J., Goodman, D. M., Steel, T. R., Kumar, S., Wieczorek, A., Walsh, F. P., Sullivan, M. P., Hanif, M., & Hartinger, C. G. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.213950 · Cited by 89 · see citing works

Identification of the Structural Determinants for Anticancer Activity of a Ruthenium Arene Peptide Conjugate

Meier, S. M., Novak, M. S., Kandioller, W., Jakupec, M. A., Arion, V. B., Metzler‐Nolte, N., Keppler, B. K., & Hartinger, C. G. (2013) · Chemistry - A European Journal · doi:10.1002/chem.201300889 · Cited by 62 · see citing works

Aluminum effects on marine phytoplankton: implications for a revised Iron Hypothesis (Iron–Aluminum Hypothesis)

Zhou, L., Tan, Y., Huang, L., Fortin, C., & Campbell, P. G. C. (2018) · Biogeochemistry · doi:10.1007/s10533-018-0458-6 · Cited by 62 · see citing works

Kojic acid derivatives as powerful chelators for iron(iii) and aluminium(iii)

Nurchi, V. M., Lachowicz, J. I., Crisponi, G., Murgia, S., Arca, M., Pintus, A., Gans, P., Gutiérrez, J. N., Domínguez‐Martín, A., Castiñeiras, A., et al. (2011) · Dalton Transactions · doi:10.1039/c1dt00005e · Cited by 53 · see citing works

New tripodal hydroxypyridinone based chelating agents for Fe(III), Al(III) and Ga(III): Synthesis, physico-chemical properties and bioevaluation

Grazina, R., Gano, L., Šebestı́k, J., & Santos, M. A. (2008) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2008.10.014 · Cited by 52 · see citing works

A gallium complex with a new tripodal tris-hydroxypyridinone for potential nuclear diagnostic imaging: solution and in vivo studies of 67Ga-labeled species

Chaves, S., Mendonça, A. C., Marques, S. M., Prata, M. I. M., SANTOS, A. C. D. S., Martins, A. F., Geraldes, C. F. G. C., & Santos, M. A. (2010) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2010.09.012 · Cited by 47 · see citing works

New Tris(hydroxypyridinones) as Iron and Aluminium Sequestering Agents: Synthesis, Complexation and In Vivo Studies

Chaves, S., Marques, S. M., Matos, A. M. F., Nunes, A. C. C., Gano, L., Tuccinardi, T., Martinelli, A., & Santos, M. A. (2010) · Chemistry - A European Journal · doi:10.1002/chem.201001335 · Cited by 46 · see citing works

Influence of the Arene Ligand and the Leaving Group on the Anticancer Activity of (Thio)maltol Ruthenium(ii)–(η6-Arene) Complexes

Hanif, M., Schaaf, P., Kandioller, W., Hejl, M., Jakupec, M. A., Roller, A., Keppler, B. K., & Hartinger, C. G. (2010) · Australian Journal of Chemistry · doi:10.1071/ch10232 · Cited by 35 · see citing works

Exploring the multifunctionality of thioflavin- and deferiprone-based molecules as acetylcholinesterase inhibitors for potential application in Alzheimer's disease

Telpoukhovskaia, M. A., Patrick, B. O., Rodríguez‐Rodríguez, C., & Orvig, C. (2013) · Molecular BioSystems · doi:10.1039/c3mb25600f · Cited by 33 · see citing works

A new tetrapodal 3-hydroxy-4-pyridinone ligand for complexation of 89 zirconium for positron emission tomography (PET) imaging

Buchwalder, C., Rodríguez‐Rodríguez, C., Schaffer, P. C., Karagiozov, S. K., Saatchi, K., & Häfeli, U. O. (2017) · Dalton Transactions · doi:10.1039/c7dt02196h · Cited by 31 · see citing works

Drug-like chelating agents: a potential lead for Alzheimer's disease

Huang, W., Wei, W., & Shen, Z. (2014) · RSC Advances · doi:10.1039/c4ra09193k · Cited by 29 · see citing works

Complexes of hydroxy(thio)pyrone and hydroxy(thio)pyridinone with Zn( ii ) and Mo( vi ). Thermodynamic stability and insulin-mimetic activity

Chaves, S., Jelić, R., Mendonça, C., Carrasco, M. P., Yoshikawa, Y., Sakurai, H., & Santos, M. A. (2009) · Metallomics · doi:10.1039/b914169c · Cited by 27 · see citing works

Microwave-assisted synthesis of 3-hydroxy-4-pyridinone/naphthalene conjugates. Structural characterization and selection of a fluorescent ion sensor

Silva, A. M. G., Leite, A., Andrade, M. A., Gameiro, P., Brandão, P., Félix, V. M. S., de Castro, B., & Rangel, M. (2010) · Tetrahedron · doi:10.1016/j.tet.2010.08.065 · Cited by 26 · see citing works

Synthesis of novel Iron(III) chelators based on triaza macrocycle backbone and 1-hydroxy-2(H)-pyridin-2-one coordinating groups and their evaluation as antimicrobial agents

Workman, D. G., Hunter, M., Dover, L. G., & Tétard, D. (2016) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2016.04.018 · Cited by 25 · see citing works

Organometallic Ruthenium and Osmium Compounds of Pyridin‐2‐ and ‐4‐ones as Potential Anticancer Agents

Henke, H., Kandioller, W., Hanif, M., Keppler, B. K., & Hartinger, C. G. (2012) · Chemistry & Biodiversity · doi:10.1002/cbdv.201200005 · Cited by 22 · see citing works

A bis(3-hydroxy-4-pyridinone)-EDTA derivative as a strong chelator for M3+ hard metal ions: complexation ability and selectivity

Gama, S., Dron, P. I., Chaves, S., Farkas, E., & Santos, M. A. (2009) · Dalton Transactions · doi:10.1039/b904950a · Cited by 21 · see citing works

Synthesis and intestinal transport of the iron chelator maltosine in free and dipeptide form

Geißler, S., Hellwig, M., Markwárdt, F., Henle, T., & Brandsch, M. (2011) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.12.032 · Cited by 21 · see citing works

The possibility of iron chelation therapy in the presence of different HPOs; a molecular approach to the non-covalent interactions and binding energies

Kaviani, S., & Izadyar, M. (2018) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2018.04.065 · Cited by 20 · see citing works

Protonation and lanthanide(iii) complexation equilibria of a new tripodal polyaza-polycatechol-amine

Bernardo, P. D., Zanonato, P., Bismondo, A., Melchior, A., & Tolazzi, M. (2009) · Dalton Transactions · doi:10.1039/b822945g · Cited by 18 · see citing works

Novel tetradentate chelators derived from 3-hydroxy-4-pyridinone units: synthesis, characterization and aqueous solution properties

Leite, A., Silva, A. M. G., Nunes, A., Andrade, M. A., Sousa, C., Cunha-Silva, L., Gameiro, P., de Castro, B., & Rangel, M. (2011) · Tetrahedron · doi:10.1016/j.tet.2011.04.035 · Cited by 17 · see citing works

Combined chelation of bi-functional bis-hydroxypiridinone and mono-hydroxypiridinone: Synthesis, solution and in vivo evaluation

Gama, S., Gil, M., Gano, L., Farkas, E., & Santos, M. A. (2008) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2008.10.020 · Cited by 17 · see citing works

A novel tripodal tris-hydroxypyrimidinone sequestering agent for trivalent hard metal ions: synthesis, complexation and in vivo studies

Chaves, S., Capelo, A., Areias, L. R. P., Marques, S. M., Gano, L., Esteves, M. A., & Santos, M. A. (2012) · Dalton Transactions · doi:10.1039/c2dt32361c · Cited by 15 · see citing works

Bifunctional 3-hydroxy-4-pyridinones as effective aluminium chelators: synthesis, solution equilibrium studies and in vivo evaluation

Irto, A., Cardiano, P., Chand, K., Cigala, R. M., Crea, F., Stefano, C. D., Gano, L., Sammartano, S., & Santos, M. A. (2018) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2018.05.017 · Cited by 15 · see citing works

New bis-(3-hydroxy-4-pyridinone)-NTA-derivative: Synthesis, binding ability towards Ca2+, Cu2+, Zn2+, Al3+, Fe3+ and biological assays

Irto, A., Cardiano, P., Chand, K., Cigala, R. M., Crea, F., Stefano, C. D., Gano, L., Gattuso, G., Sammartano, S., & Santos, M. A. (2018) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2018.09.107 · Cited by 15 · see citing works

Combined chelation based on glycosyl-mono- and bis-hydroxypyridinones for aluminium mobilization: Solution and biodistribution studies

Chaves, S., Dron, P. I., Danalache, F. A., Sacoto, D., Gano, L., & Santos, M. A. (2009) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2009.07.026 · Cited by 14 · see citing works

Functionalization of Ruthenium(II)(η6‐p‐cymene)(3‐hydroxy‐2‐pyridone) Complexes with (Thio)Morpholine: Synthesis and Bioanalytical Studies

Hanif, M., Meier, S. M., Adhireksan, Z., Henke, H., Martić, S., Movassaghi, S., Labib, M., Kandioller, W., Jamieson, S. M. F., Hejl, M., et al. (2017) · ChemPlusChem · doi:10.1002/cplu.201700050 · Cited by 14 · see citing works

High Antiproliferative Activity of Hydroxythiopyridones over Hydroxypyridones and Their Organoruthenium Complexes

Shakil, M. S., Parveen, S., Rana, Z., Walsh, F. P., Movassaghi, S., Söhnel, T., Azam, M., Shaheen, M. A., Jamieson, S. M. F., Hanif, M., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9020123 · Cited by 10 · see citing works

Hydroxypyrone derivatives in drug discovery: from chelation therapy to rational design of metalloenzyme inhibitors

Arshad, J. Z., & Hanif, M. (2022) · RSC Medicinal Chemistry · doi:10.1039/d2md00175f · Cited by 10 · see citing works

New hydroxypyridinone-functionalized sepharoses as sorbing agents for hard metal ions

Grazina, R., & Santos, M. A. (2010) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2010.12.084 · Cited by 10 · see citing works

The Literature of Heterocyclic Chemistry, Part XI, 2008–2009

Belen’kii, L. I., & Evdokimenkova, Y. B. (2012) · Advances in heterocyclic chemistry · doi:10.1016/b978-0-12-404598-9.00003-1 · Cited by 10 · see citing works

Aluminium, gallium, indium and thallium

López, C. A. (2009) · Annual Reports Section A (Inorganic Chemistry) · doi:10.1039/b910413p · Cited by 9 · see citing works

Syntheses and crystal structures of metal (Mn, Co, Ni) chloride complexes with 3-hydroxypyridin-2-one and contribution of O H⋯Cl hydrogen bonds to their structural diversity

Petriček, S. (2019) · Polyhedron · doi:10.1016/j.poly.2019.03.050 · Cited by 7 · see citing works

Synthesis and characterization of a new 4-pyridone derivative and its complexation of iron(III)

Ivšić, A. G., Tomišić, V., Car, Ž., Prugovečki, B., & Tomić, S. (2011) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2011.01.051 · Cited by 6 · see citing works

Synthesis, physicochemical characterization and neuroprotective evaluation of novel 1-hydroxypyrazin-2(1 H )-one iron chelators in an in vitro cell model of Parkinson's disease

Lewis, F. W., Bird, K., Navarro, J.-P., Fallah, R. E., Brandel, J., Hubscher‐Bruder, V., Tsatsanis, A., Duce, J. A., Tétard, D., Bourne, S., et al. (2022) · Dalton Transactions · doi:10.1039/d1dt02604f · Cited by 5 · see citing works

Epoxidation of strained alkenes catalysed by (1,2-dimethyl-4(1H)pyridinone-3-olate)2MnIIICl

Robinson-Miller, A., Wyatt, M. F., & Tétard, D. (2014) · Journal of Molecular Catalysis A Chemical · doi:10.1016/j.molcata.2014.12.012 · Cited by 5 · see citing works

Coordination and solution chemistry of the metals: biological, medical and environmental relevance.

Ruggiero, C. (2011) · Wiley eBooks · doi:10.1002/9780470976548.ch9 · Cited by 5 · see citing works

Gallium: Inorganic Chemistry

Banger, K. K. (2015) · Encyclopedia of Inorganic and Bioinorganic Chemistry · doi:10.1002/9781119951438.eibc0072.pub2 · Cited by 3 · see citing works

3-Hidroksipiridin-4-oni (II. dio): Biološka primjena kao kelatora željeza

Zavod za organsku kemiju, K. O., Car, Ž., Peroković, V. P., Zavod za organsku kemiju, K. O., Tomić, S., & Zavod za organsku kemiju, K. O. (2017) · Kemija u industriji · doi:10.15255/kui.2015.051 · Cited by 2 · see citing works

Defined and refined: development of a minimal medium for Clostridium pasteurianum

Alemany, N. N., Verboon, D. C., Kleerebezem, R., & González‐Cabaleiro, R. (2025) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-025-13572-5 · Cited by 1 · see citing works

Toxic impact of aluminium on the natural phytoplankton community during spring in the Atlantic sector of the Southern Ocean

Demasy, C., Singh, A., Samanta, S., Ryan-Keogh, T. J., & Roychoudhury, A. N. (2025) · Journal of Experimental Marine Biology and Ecology · doi:10.1016/j.jembe.2025.152119 · Cited by 1 · see citing works

Synthesis of New Bis(3-hydroxy-4-pyridinone) Ligands as Chelating Agents for Uranyl Complexation

Jin, B., Zheng, R., Peng, R., & Chu, S. (2016) · Molecules · doi:10.3390/molecules21030299 · Cited by 1 · see citing works

Aluminium

Exley, C. (2014) · Royal Society of Chemistry eBooks · doi:10.1039/9781849739979-00833 · Cited by 1 · see citing works

An Overview of Multifunctional Metal Chelators as Potential Treatments for Neurodegenerative Diseases

Lewis, F. W., & Tétard, D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804562-6.00020-8 · Cited by 1 · see citing works

Diaqua(2,6-dihydroxybenzoato-κ2O1,O1′)bis(2,6-dihydroxybenzoato-κO1)bis(1,10-phenanthroline-κ2N,N′)lanthanum(III)–1,10-phenanthroline (1/1)

Cai, Y., Dong, W., & Jin, H. (2010) · Acta Crystallographica Section E Structure Reports Online · doi:10.1107/s1600536810047318

Efeito da especiação química sobre a absorção de ferro em Symbiodiniaceae

Romero, J. M. D. (2020) · doi:10.11606/d.46.2020.tde-26042022-100304

BindingDB Entry 50018683: Hydroxypyrone derivatives in drug discovery: from chelation therapy to rational design of metalloenzyme inhibitors.

BindingDB (2024) · UC San Diego · doi:10.7270/q21n85b2

Combined chelation of bi-functional bis-hydroxypiridinone and mono-hydroxypiridinone: Synthesis, solution and in vivo evaluation

Gama, S., Gil, M., Gano, L., Farkas, E., & Santos, M. A. (2008) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2008.10.020 · Cited by 17 · see citing works

Synthesis, Physicochemical Properties, and Evaluation ofN-Substituted-2-alkyl-3-hydroxy-4(1H)-pyridinones

Rai, B. L., Dekhordi, L. S., Khodr, H., Jin, Y., Liu, Z. D., & Hider, R. C. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9707784 · Cited by 108 · see citing works

A bis(3-hydroxy-4-pyridinone)-EDTA derivative as a strong chelator for M3+ hard metal ions: complexation ability and selectivity

Gama, S., Dron, P. I., Chaves, S., Farkas, E., & Santos, M. A. (2009) · Dalton Transactions · doi:10.1039/b904950a · Cited by 21 · see citing works

Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential

Dobbin, P. S., Hider, R. C., Hall, A. D., Taylor, P. D., Sarpong, P., Porter, J. B., Xiao, G., & der Helm, D. V. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00069a002 · Cited by 217 · see citing works

New Tris(hydroxypyridinones) as Iron and Aluminium Sequestering Agents: Synthesis, Complexation and In Vivo Studies

Chaves, S., Marques, S. M., Matos, A. M. F., Nunes, A. C. C., Gano, L., Tuccinardi, T., Martinelli, A., & Santos, M. A. (2010) · Chemistry - A European Journal · doi:10.1002/chem.201001335 · Cited by 46 · see citing works